VB Spine Announces Intent to Acquire Exclusive Rights to Augmedics’ Spine Platform VB Spine LLC the largest privately held spine company, today announced it has entered into a definitive agreement to acquire exclusive rights to the xvision Spine System® (xvision) from Augmedics,…
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted…
Owlet Announces Strategic DME Partnership with PromptCare to Expand Distribution of Pediatric Pulse Oximeter, BabySat® Owlet, Inc. the pioneer of smart infant monitoring, today announced a new strategic partnership with PromptCare, a leading national respiratory services and durable medical equipment (DME)…
WHOOP Launches Advanced Labs in the UAE with Diagnostic Partner Unilabs, Delivering A Comprehensive View of Health For Members WHOOP, the human performance company, today announced a partnership with Unilabs, a leading international provider of medical diagnostic services, to expand…
Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening Median Technologies developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early…
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for…
GE HealthCare and CDL Nuclear Technologies Partner to Expand Access to Flyrcado™, a Novel Cardiac PET Imaging Agent, Across the United States GE HealthCare (Nasdaq: GEHC) has announced a pivotal Distribution and Services Agreement (DSA) with CardioNavix, a division of…
PureTech Showcases Differentiated IPF Strategy, Highlights Patient Insights, and Positions Deupirfenidone as a Potential New Standard of Care PureTech Health plc (Nasdaq: PRTC, LSE: PRTC), a clinical-stage biotherapeutics company devoted to transforming outcomes for patients facing devastating diseases, took center…
PureTech Health Launches Celea Therapeutics to Transform the Treatment Landscape for Respiratory Diseases PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company committed to developing groundbreaking therapies for patients with devastating conditions, has announced…
NorthStar Medical Technologies Appoints Jon Coulter as Non-Executive Chairman, Marking a Key Step in Leadership Succession for Continued Growth in the Radiopharmaceutical Sector NorthStar Medical Technologies, LLC, a recognized global innovator in the development, production, and commercialization of advanced radiopharmaceuticals…
Genentech and Roche Unveil Comprehensive Advances in Alzheimer’s Disease Research at AAIC 2025 At the 2025 Alzheimer’s Association International Conference (AAIC), held in Toronto from July 27 to 30, Genentech and Roche took center stage with a sweeping showcase of…
EyeDura Therapeutics Wins Top Industry Honors as Its Sustained-Release Eye Drop Technology Gains Momentum in Ophthalmology Innovation EyeDura Therapeutics Inc., a trailblazing developer of preservative-free, sustained-release ophthalmic therapies, has garnered prominent recognition across two of the ophthalmology industry’s most respected…
